A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy.
about
Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK in vitro.Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach.Drug Repurposing of Metabolic Agents in Malignant Glioma
P2860
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@en
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@nl
type
label
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@en
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@nl
prefLabel
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@en
A phase I study to repurpose d ...... stoma after chemoradiotherapy.
@nl
P2093
P2860
P1476
A phase I study to repurpose d ...... astoma after chemoradiotherapy
@en
P2093
A Craig Lockhart
Albert H Kim
Christina I Tsien
David D Tran
Jian L Campian
Todd A DeWees
P2860
P2888
P304
P356
10.1007/S11060-016-2104-2
P577
2016-03-10T00:00:00Z